E-LIB Suche - Ergebnisse für: Nasser, Azmi

1

Impact of Viloxazine Extended-Release Capsules (Qelbree®) o..:

Wang, Zhao ; Liranso, Tesfaye ; Maldonado-Cruz, Zulane..
Clinical Drug Investigation. 44 (2024) 5 - p. 303-317 , 2024

2

Model-based comparison of subcutaneous versus sublingual ap..:

Nasser, Azmi ; Gomeni, Roberto ; Ceresoli-Borroni, Gianpiera...
Journal of Pharmacokinetics and Pharmacodynamics. , 2024

Link: https://doi.org/10.1007/..

3

Correction: Model-based comparison of subcutaneous versus s..:

Nasser, Azmi ; Gomeni, Roberto ; Ceresoli-Borroni, Gianpiera...
Journal of Pharmacokinetics and Pharmacodynamics. , 2024

Link: https://doi.org/10.1007/..

4

Advanced Model-based Approach to Evaluate Human Plasma, Cer..:

Nasser, Azmi ; Randall Owen, J. ; Gomeni, Roberto...
Clinical Therapeutics. 46 (2024) 3 - p. 217-227 , 2024

Link: https://doi.org/10.1016/..

5

Continuous, Subcutaneous Apomorphine Infusion for Persisten..:

Isaacson, Stuart ; Ceresoli-Borroni, Gianpiera ; Espay, Alberto...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

6

Evaluating the Impact of Caffeine on the Incidence of Adver..:

Nasser, Azmi ; Gomeni, Roberto ; Hull, Joseph...
CNS Spectrums. 28 (2023) 2 - p. 234-235 , 2023

Link: https://doi.org/10.1017/..

7

Response of peer relations and social activities to treatme..:

Faraone, Stephen V. ; Gomeni, Roberto ; Hull, Joseph T....
Brain and Behavior. 13 (2023) 4 - p. , 2023

Link: https://doi.org/10.1002/..

8

Effects of Viloxazine ER (Qelbree®) on Weight and Height Tr..:

Nasser, Azmi ; Hull, Joseph ; Earnest, Jami...
CNS Spectrums. 28 (2023) 2 - p. 218-218 , 2023

Link: https://doi.org/10.1017/..

9

Impact of Viloxazine Extended-Release Capsules (Qelbree®) o..:

Nasser, Azmi ; Hull, Joseph ; Yarullina, Ilmiya..
CNS Spectrums. 28 (2023) 2 - p. 218-219 , 2023

Link: https://doi.org/10.1017/..

10

Predicting efficacy of viloxazine extended-release treatmen..:

Faraone, Stephen V. ; Gomeni, Roberto ; Hull, Joseph T....
Psychiatry Research. 318 (2022) - p. 114922 , 2022

Link: https://doi.org/10.1016/..

11

A Phase III, Randomized, Double-Blind, Placebo-Controlled T..:

Nasser, Azmi ; Hull, Joseph T. ; Chaturvedi, Soumya A....
CNS Drugs. 36 (2022) 8 - p. 897-915 , 2022

Link: https://doi.org/10.1007/..

12

An Open-Label Pilot Trial Assessing the Safety and Efficacy..:

Portelli, Jeanelle ; Park, Lovingly ; Lujan, Brendan...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

13

Authors' Reply to Singh and Balasundaram: Comment on "A Pha..:

Nasser, Azmi ; Hull, Joseph T. ; Liranso, Tesfaye...
CNS Drugs. 36 (2022) 12 - p. 1333-1335 , 2022

Link: https://doi.org/10.1007/..

14

The role of placebo response in the efficacy outcome assess..:

Nasser, Azmi ; Gomeni, Roberto ; Wang, Zhao...
British Journal of Clinical Pharmacology. 88 (2022) 11 - p. 4828-4838 , 2022

Link: https://doi.org/10.1111/..

15

Early response to SPN-812 (viloxazine extended-release) can..:

Faraone, Stephen V. ; Gomeni, Roberto ; Hull, Joseph T....
Psychiatry Research. 296 (2021) - p. 113664 , 2021

Link: https://doi.org/10.1016/..